Topics

Companies Related to "Akebia Therapeutics Participate Upcoming Investor Conferences" [Most Relevant Company Matches] RSS

11:59 EDT 21st September 2019 | BioPortfolio

Here are the most relevant search results for "Akebia Therapeutics Participate Upcoming Investor Conferences" found in our extensive corporate database of over 50,000 company records.

Showing "Akebia Therapeutics Participate Upcoming Investor Conferences" Companies 1–25 of 2,400+

Extremely Relevant

Akebia Therapeutics, Inc. 

Akebia Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor biology. For more information, please visit our website at www.akebia.com, which does not form a part of this release.


Akebia Therapeutics, Inc. and Keryx Biopharmaceuticals, Inc.

Akebia Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor biology. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics, Inc.

Akebia Therapeutics is a discovery and development company focused on anemia and vascular disorders. Akebia’s lead program, AKB-6548, an orally bioavailable HIF-prolyl hydroxylase (HIF-PH) inhibitor for patients with anemia, is in phase 2 clinical trials. AKB-6548 potentially promises to be a safer, less expensive, orally dosed pharmaceutical to stimu...


Relevant

Akebia Therapeutics, Inc. and The Vifor Pharma Group

The Williamsburg BioProcessing

The Williamsburg BioProcessing Foundation was established in 1994 to provide venues for the exchange of bioprocess technology. Whereas other conferences were known to adequately cover the scientific, regulatory, and clinical issues associated with biotechnology, we felt there was a need for meetings that provided a thorough coverage of process development and production issues while focusing on na...

LaVoieHealthScience

LaVoieHealthScience partners with leading life science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations....

Pharmaceutical Executive Conferences website

Welcome to the Pharmaceutical Executive Conferences website Pharmaceutical Executive Conferences provide top industry gatherings for up-to-the-minute information and unmatched opportunity to interact with other pharmaceutical industry executives. Every Pharmaceutical Executive Conference offers rich content presented in an opportune setting for the exchange of ideas and solutions to today’s indu...

Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC

Heartland Advisors, Inc.

Heartland Advisors, Inc. is an independently owned Milwaukee-based firm established in 1983 and renowned as America’s Value Investor®. As of May 31, 2012, the firm managed approximately $4.9 billion for institutional and high net worth clients and the Heartland family of value-driven mutual funds, which include the Heartland Value Fund (Investor: HRTVX), ...

International Business Forum, Inc.

IBF*International Business Forum, Inc. is a leading presenter of venture capital, technology innovation and private equity conferences in the United States. For 20 years, IBF has been presenting conferences which unite investors, emerging growth companies and corporations. IBF produces conferences on the following venture capital subjects: Venture Capital Investing, Early Stage Investing, Cleantec...

Bio/Med Investor Network

The Bio/Med Investor Network was formed in 2014 to address the need for funding in early-stage bioscience and healthcare companies. Network members are accredited angel investors specializing in these fields to provide a high level of scrutiny and guidance for growing companies. The Network is based in Atlanta, Georgia with about 40 investor/members. More ...

dvm360

dvm360®, the leading media-content provider in the veterinary market in operation for more than 30 years, provides readers with top-of-the-line content that focuses on every aspect of a veterinary professional’s life. dvm60® also hosts continuing education (CE) conferences that offer a 360-degree educational engagement experience for veterinary ...

dvm360®

dvm360®, the leading media-content provider in the veterinary market in operation for more than 30 years, provides readers with top-of-the-line content that focuses on every aspect of a veterinary professional’s life. dvm360® also hosts continuing education (CE) conferences that offer a 360-degree educational engagement experience for veterinary ...

American Council on Science and Health

The American Council on Science and Health (ACSH) is a consumer education consortium concerned with issues related to food, nutrition, chemicals, pharmaceuticals, lifestyle, the environment and health. ACSH is an independent, nonprofit, tax-exempt organization. The nucleus of ACSH is a board of 350 physicians, scientists and policy advisors - experts in a wide variety of fields-who review the Coun...

Investor Protection Trust, Investor Protection Institute and National Adult Protective Services Association

Owicki Consulting

Prior to becoming a consultant in 1999, I held technical and executive corporate positions (e.g., V.P. of Research at LJL BioSystems, Inc.) and an academic post (Assoc. Prof. of Biophysics, U.C. Berkeley). Other professional activities include membership on several journal editorial boards, organizing sessions at conferences, and speaking at conferences.

Jounce Therapeutics

Jounce Therapeutics is dedicated to transforming the treatment of cancer. The company is discovering and developing first-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. Jounce’s proprietary product engine is driving this transformational approach, which has the potential to driv...

Jounce Therapeutics, Inc.

Jounce Therapeutics is dedicated to transforming the treatment of cancer. The company is discovering and developing novel cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. Jounce’s proprietary product engine is driving this transformational approach, which has the potential to drive signifi...

First Conferences

Launched in June 1990 in London, First Conferences Ltd [FC] quickly grew to become a significant player in the global events market.Our policy of encouraging entrepreneurship and offering high levels of employee autonomy quickly attracted a dynamic team able to work effectively in any market, in any industry and on any opportunity

Scivent

SCIVENT is your competent partner for the planning, organization, and realization of conferences business meetings round table discussions lecture series product introductions employee or customer trainingWith SCIVENT, you can concentrate completely on your most important tasks. Scivent develops and markets your ideas and concepts for new conferences and events.

Jecure Therapeutics Inc.

Jecure Therapeutics is focused on the discovery of novel therapeutics for the treatment of NASH and liver fibrosis. Jecure’s scientific founder is Dr. Ariel Feldstein, Division Chief of Gastroenterology at UCSD School of Medicine and a leading physician scientist in hepatology. With operations in the biotech hub of San Diego, California, Jecure combin...

Developmentr institute international

Dii was established in 1993 with the objective of providing the best quality of information conferences and trainings to business executives in France. In less than 15 years, most of Dii's annual conferences have become the "must attend" event for its industry. Thanks to its dynamic, client driven and efficient team, Dii has been successful to respond to the specific needs of the Franco-phone mark...

Michael Murphy's New World Investor

This is a solicitation for Michael Murphy's New World Investor, a weekly general interest newsletter which is not liable for the suitability or future investment performance of any securities or strategies discussed. Historical investment return examples given are hypothetical, and not to be taken as representative of any individual's actual trading experience. For access to our full disclaimer an...

Complete Growth Investor LLC

Tom is the old man of the Complete Growth Investor team, beginning his investing career as a teenager in 1968 with two shares of Ford Motor. His value investing orientation is heavily influenced by his parents' experience of the Crash of '29 and Great Depression and his own in the other two great bubbles, the 1960s Go-Go Years and 1999-2000.Tom puts his money where his mouth is by owning every sto...

Trout Group

The Trout Group was founded in 1995 to provide high level investor relations services to the biotechnology industry. Our experience and knowledge of the industry have allowed us to grow into a leading investor relations firm in the sector. We have a global reach, with clients, offices or contacts in all of the major global financial centers.Since our inception, we have helped over 100 public and p...


More From BioPortfolio on "Akebia Therapeutics Participate Upcoming Investor Conferences"

Quick Search

Corporate Database Quicklinks